Equisolon 33 mg/g - Oral powder
Equisolon 33 mg/g - Oral powder
Authorised
- Prednisolone
Product identification
Medicine name:
Equisolon 33 mg/g - Oral powder
Active substance:
- Prednisolone
Target species:
-
Horse
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Prednisolone33.00/milligram(s)1.00Jar
Pharmaceutical form:
-
Oral powder
Withdrawal period by route of administration:
-
Oral use
-
Horse
-
Meat and offal10day10 days (Not authorised for use in mares producing milk for human consumption)
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QH02AB06
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Liechtenstein
-
Lithuania
-
Luxembourg
-
Malta
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
Available in:
-
Austria
-
Belgium
-
Denmark
-
Finland
-
France
-
Germany
-
Italy
-
Netherlands
-
Norway
-
Poland
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
Package description:
- Packaging:Jar (HDPE), Package_size:1 jar (180 g) with polystyrene measuring spoon
- Packaging:Jar (HDPE), Package_size:1 jar (504 g) with polystyrene measuring spoon
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Le Vet. B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Lelypharma B.V.
Responsible authority:
- European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet